Leprosy
Mailing List, December 2nd, 2008
Ref.: Steroid
therapy in the management of reactions in leprosy (see attachment1 & attachment 2)
From: Naafs B., Bauru, SP,
Brazil
Dear
Salvatore,
I agree fully with you (LML Nov. 30th, 2008) that there is
NO EVIDENCE at all, for the 3-month steroid treatment. It is too short for quite a
number of patients. Many patients
deteriorate after the cessation of the 3 month treatment.
Unluckily for them often the damage is silent. I had hoped that after my
papers, which are enclosed (attachment 1
and attachment 2 in PDF format),
people would come to their senses. I am of the opinion that to
continue the 3 month advice is unscientific and would not hold in
any court. I think it is
near criminal to neglect the accumulated evidence against only 3 month
of treatment in Type I reaction, where it invites problems when
you use it in Type 2 reactions.
Why do WHO "experts" not listen to patients and their
doctors and do not realise that leprosy is a spectral disease and
moreover that leprosy in one geographical area is not that in
another and that just looking at the
Bangladesh
trials is short-sighted and biased.
Greetings from
Brazil
,
Ben Naafs
